Showing results (1711-1720 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|September 14, 2013
Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemiaWenjian Guo, Chao Xing, Aishu Dong, et al.Cancer Biology & Therapy|August 7, 2013
PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cellsLaurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.Cancer Biology & Therapy|August 7, 2013
Novel antioxidants are not toxic to normal tissues but effectively kill cancer cellsAnna Kovalchuk, Felix Aladedunye, Rocio Rodriguez-Juarez, et al.Cancer Biology & Therapy|August 7, 2013
Endoglin is necessary for angiogenesis in human ovarian carcinoma-derived primary endothelial cellsYan Xu, Dan Wang, Li-Mei Zhao, et al.Cancer Biology & Therapy|August 7, 2013
Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growthMelanie Mediavilla-Varela, Kimberly Luddy, David Noyes, et al.Cancer Biology & Therapy|October 9, 2013
Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cellsKe Liang, Songbo Qiu, Yang Lu, et al.Cancer Biology & Therapy|June 25, 2013
FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancerBora Lim, Angelique Scicchitano, Cheryl Beachler, et al.Cancer Biology & Therapy|June 25, 2013
Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapyMelissa Heffler, Vita M Golubovskaya, Kelli M Bullard Dunn, et al.Cancer Biology & Therapy|June 25, 2013
Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancerXiaoqi Xie, John E Kerrigan, Tamara Minko, et al.Cancer Biology & Therapy|June 25, 2013
Contradictory KRAS mutation test results in a patient with metastatic colon cancer: a clinical dilemma in the era of personalized medicineNicholas E Lamparella, Bikramajit S Saroya, Zhaohai Yang, et al.Pageof 389